Actavis CEO Says Health Law May Boost Generics Use

Feb. 15 (Bloomberg) -- Paul Bisaro, chief executive officer of Actavis Inc., talks about the impact of the U.S. Affordable Care Act on the pharmaceutical industry, so-called biosimilars, generic versions of biotechnology drugs, and the outlook for growth. He speaks with Mark Crumpton on Bloomberg Television's "Bottom Line." (Source: Bloomberg)
Hacker Teen Uses 'Swatting' to Harass Online Gamers
32:34 - Bloomberg's Emily Chang reports on the teenage hacker who admitted to "swatting" online gamers. She speaks on "Bloomberg West." (Source: Bloomberg)
  • How Close Are We to an Uber IPO?
  • The Top Three Things to Watch for at Google I/O
  • U.S. Economy Set Up for Sept. or Oct. Rate Hike: Kleintop